Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C

Updated: Dec 14, 2020

Holeksa J, Magel T, Alimohammadi A, Thiam A, Yung R, Chu L, Truong D, Conway B. Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C infection in Vancouver, Canada. International Journal of Drug Policy. 2019; 17


Full text: https://doi.org/10.1016/j.drugpo.2019.05.024


Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in some cohorts. The aim of this study was to evaluate reinfection following successful treatment for hepatitis C virus infection in a cohort of people who inject drugs in Vancouver, Canada.

Recent Posts

See All

© 2020 by Vancouver Infectious Diseases Centre. 

logo%20png_edited.png